基本信息 |
|
| 产品名称： | 盐酸阿雷素 |
| CAS： | 25316-40-9 ;23214-92-8 |
| 中文同义词： | 盐酸阿雷素 ; 盐酸阿霉素 ; 盐酸多柔比星 |
| 英文同义词： | DOX ; DOXORUBICIN HYDROCHLORIDE ; DOXORUBICIN ; ADRIAMYCIN(DOXORUBICIN)/ ; (8S,10S)-10-[(3-AMINO-2,3,6-TRIDEOXY-ALPHA-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE ; DOXORUBICINE HCL ; CAELYX HYDROCHLORIDE ; ADRIAMYCIN HYDROCHLORIDE ; DOXORUBCIN HYDROCHLORIDE ; ADRIACIN HYDROCHLORIDE ; DOX HYDROCHLORIDE ; NSC 123127 HYDROCHLORIDE ; RUBEX HYDROCHLORIDE ; ADRIBLASTINA HYDROCHLORIDE ; ADRIAMYCIN HCL ; DOXORUBICIN HCL ; DOXORUBICIN HYDROCHLORIDE, 99% ; DOXORUBICIN HCL SALT ; HYDROXYDAUNORUBICIN HYDROCHLORIDE ; (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL-(3-AMINO-2,3,6-TRIDESOXY-ALPHA-L-LYXO-HEXOPYRANOSID) HYDROCHLORIDE ; DOXORUBICIN (HYDROCHLORIDE) ; ADRIAMYCIN ; 14-HYDROXYDAUNOMYCIN HYDROCHLORIDE ; ADRIBLASTINA ; 14-HYDROXYDAUNOMYCIN HCL ; DOXORUBICIN(ADRIAMYCIN) HYDROCHLORIDE ; 5,12-NAPHTHACENEDIONE, 10-[(3-AMINO-2,3,6-TRIDEOXY-A-L-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-, HYDROCHLORIDE (1:1), (8S,10S)- |
| MDL号： | MFCD00077757 |
| 氢键受体数量： | 12 |
| 氢键供体数量： | 6 |
| Smile： | C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O.Cl |
| InChi： | InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1 |
| InChiKey： | InChIKey=MWWSFMDVAYGXBV-RUELKSSGSA-N |
性质 |
|
| 熔点： | 216 DEG C (DEC)(LIT) |
| 注解： | BIOCHEM/PHYSIOL ACTIONS: ANTITUMOUR ANTIBIOTIC. EFFECT OF ADRIAMYCIN(R) ON HEART MITOCHONDRIAL DNA PROPERTIES BIOCHEM/PHYSIOL ACTIONS: IMMUNOSUPPRESSIVE AGENT BIOCHEM/PHYSIOL ACTIONS: INHIBITOR OF REVERSE TRANSCRIPTASE AND RNA POLYMERASE BIOCHEM/PHYSIOL ACTIONS: INTERCALATES IN DNA GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA LEGAL INFORMATION: ADRIAMYCIN IS A REGISTERED TRADEMARK OF RDF PHARMACIA AND UPJOHN S PA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
安全信息 |
|
| 符号： |
GHS07
GHS08
|
| 信号词： | Danger |
| 危险声明： | H302-H315-H319-H350 |
| 警示性声明： | P201-P305 + P351 + P338-P308 + P313 |
| 危害码： | T,Xi |
| 风险声明： | R:45-22-36/38 |
| 安全声明： | S:53-45 |
| WGK德国： | 3 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2025 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号
English
